Previous 10 | Next 10 |
Gainers: Technical Communications (NASDAQ: TCCO ) +323% . More news on: Technical Communications Corporation, Venus Concept Inc., Iterum Therapeutics plc, Stocks on the move, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ) announces an update on the cytisinicline clinical development program. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SEATTLE and VANCOUVER, British Columbia , Dec. 9, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
Achieve Life Sciences, Inc. (ACHV) Q3 2019 Earnings Conference Call November 6, 2019 8:00 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Rick Stewart - Chief Executive Officer John Bencich - Chief Financial and Operating Officer Cindy Jacobs - C...
Fluidigm (NASDAQ: FLDM ) -31% on Q3 results . More news on: Fluidigm Corporation, Plantronics, Inc., Amneal Pharmaceuticals, Inc., Stocks on the move, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.45 misses by $0.15 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , Nov. 6, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
SEATTLE and VANCOUVER, British Columbia , Oct. 31, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotin...
Achieve Life Sciences (NASDAQ: ACHV ) confirms that it will evaluate 3 mg of smoking cessation med cytisinicline dosed three times per day in its Phase 3 program that will launch in 2020 subject to sufficient capital. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, ...
Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (S...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...